Colchicine trial for better heart artery reopening after ACS
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether colchicine (a medicine commonly used for inflammation) can improve how well clogged heart arteries reopen after a short-term heart emergency called ACS. You may be eligible if you’re hospitalized with ACS and are planned for a coronary angiogram and possible angioplasty soon.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You’re currently hospitalized for acute coronary syndrome (ACS), usually with chest pain and a blood test showing heart injury (troponin above normal).
- A heart procedure called coronary angiography is planned during this hospital stay, with angioplasty expected soon.
- You must be able and willing to sign written informed consent.
- You’re not able to join if your ACS is an ST-elevation heart attack needing emergency angioplasty right away.
- You must not have certain heart/liver/kidney problems, serious drug interactions, pregnancy or breastfeeding, or known colchicine intolerance.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a low dose of the anti-inflammatory drug colchicine can help people who have recently had a heart attack or unstable angina. It aims to see if colchicine reduces the risk of future heart problems.
This trial is for people who had a heart attack and received a specific type of stent (Orsiro). It tests a combination of a single antiplatelet drug and colchicine to see if it helps prevent future heart problems. Colchicine is a medicine that reduces inflammation and might lower the risk of another heart attack.
This trial tests if colchicine, an anti-inflammatory medicine, can help people who recently had a heart attack. It looks for markers in your blood to see who might benefit most.
This trial tests if the anti-inflammatory drug colchicine can help people with non-severe coronary artery plaque seen on a CT scan. It may be an option if you have stable chest pain or related symptoms and your heart arteries are partly blocked but not severely.
This study tests whether a low-dose medicine called colchicine can reduce inflammation and slow down artery blockages in people who have a specific gene change (TET2) and have recently had a heart attack. The goal is to see if it helps prevent future heart problems.
This trial tests if colchicine, a common anti-inflammatory medicine, can help prevent future heart problems in people who have coronary artery disease and recently had a stent placed. It's for adults with at least one extra risk factor like diabetes, smoking, or high blood pressure.
Hear when a new Acute Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.